JP2021520837A5 - - Google Patents
Info
- Publication number
- JP2021520837A5 JP2021520837A5 JP2020557945A JP2020557945A JP2021520837A5 JP 2021520837 A5 JP2021520837 A5 JP 2021520837A5 JP 2020557945 A JP2020557945 A JP 2020557945A JP 2020557945 A JP2020557945 A JP 2020557945A JP 2021520837 A5 JP2021520837 A5 JP 2021520837A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- nucleotides
- abca4
- exons
- splicing
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024073380A JP2024099770A (ja) | 2018-04-17 | 2024-04-30 | トランススプライシング分子 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862658667P | 2018-04-17 | 2018-04-17 | |
| US201862658658P | 2018-04-17 | 2018-04-17 | |
| US62/658,658 | 2018-04-17 | ||
| US62/658,667 | 2018-04-17 | ||
| PCT/US2019/027981 WO2019204514A1 (en) | 2018-04-17 | 2019-04-17 | Trans-splicing molecules |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024073380A Division JP2024099770A (ja) | 2018-04-17 | 2024-04-30 | トランススプライシング分子 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021520837A JP2021520837A (ja) | 2021-08-26 |
| JP2021520837A5 true JP2021520837A5 (https=) | 2022-04-25 |
| JPWO2019204514A5 JPWO2019204514A5 (https=) | 2022-04-25 |
| JP7561624B2 JP7561624B2 (ja) | 2024-10-04 |
Family
ID=68239871
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020557945A Active JP7561624B2 (ja) | 2018-04-17 | 2019-04-17 | トランススプライシング分子 |
| JP2024073380A Pending JP2024099770A (ja) | 2018-04-17 | 2024-04-30 | トランススプライシング分子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024073380A Pending JP2024099770A (ja) | 2018-04-17 | 2024-04-30 | トランススプライシング分子 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11993776B2 (https=) |
| EP (1) | EP3781213A4 (https=) |
| JP (2) | JP7561624B2 (https=) |
| KR (2) | KR102866133B1 (https=) |
| CN (1) | CN112449605A (https=) |
| AU (1) | AU2019255708B2 (https=) |
| BR (1) | BR112020021228A2 (https=) |
| CA (1) | CA3097004A1 (https=) |
| IL (1) | IL278019A (https=) |
| MX (2) | MX2020010959A (https=) |
| WO (1) | WO2019204514A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3097004A1 (en) | 2018-04-17 | 2019-10-24 | The Trustees Of The University Of Pennsylvania | Trans-splicing molecules |
| WO2020214973A1 (en) * | 2019-04-17 | 2020-10-22 | The Trustees Of The University Of Pennsylvania | Triple helix terminator for efficient rna trans-splicing |
| WO2022165313A1 (en) | 2021-02-01 | 2022-08-04 | Regenxbio Inc. | Gene therapy for neuronal ceroid lipofuscinoses |
| AU2022337146A1 (en) | 2021-09-03 | 2024-03-14 | Tacit Therapeutics, Inc. | Rna editing via recruitment of spliceosome components |
| AU2023269865A1 (en) * | 2022-05-13 | 2024-11-21 | Ascidian Therapeutics, Inc. | Abca4 trans-splicing molecules |
| WO2024011203A2 (en) * | 2022-07-07 | 2024-01-11 | Intergalactic Therapeutics, Inc. | Ocular vectors and uses thereof |
| EP4594505A1 (en) * | 2022-09-30 | 2025-08-06 | Centre National de la Recherche Scientifique | Therapy by trans-splicing of opa1 pre-messenger rnas for the treatment of diseases associated with opa1 gene mutations |
| CN121099993A (zh) * | 2023-02-15 | 2025-12-09 | 海鞘治疗公司 | Htt反式剪接分子 |
| WO2025166360A1 (en) * | 2024-02-03 | 2025-08-07 | Duke University | Compositions for and methods of engineering the transcriptome |
| WO2026012439A1 (en) * | 2024-07-11 | 2026-01-15 | Sichuan Real & Best Biotech Co., Ltd. | Rna trans-splicing molecules and systems |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6280978B1 (en) | 1995-12-15 | 2001-08-28 | Intronn Holdings, Llc | Methods and compositions for use in spliceosome mediated RNA trans-splicing |
| DE69636937T3 (de) | 1995-12-15 | 2011-01-05 | Virxsys Corp. | Durch trans-spaltung erhaltene therapeutische molekule |
| JP2001510557A (ja) | 1996-10-04 | 2001-07-31 | イントロン エルエルシー | サンプル収集デバイス及びマーカーを用いたサンプル収集方法、及びサンプル確認、ラボの評価及び／又は認定の際の比較試料としてのマーカーの使用 |
| US6929907B2 (en) | 1999-12-31 | 2005-08-16 | North Carolina State University | Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| JP4500540B2 (ja) | 2001-06-29 | 2010-07-14 | ヴェリ‐キュー，インコーポレイテッド | 化学的に合成された核酸の純度を決定し、かつ化学的に合成された核酸を精製するための方法および組成物 |
| JP2006505242A (ja) | 2002-02-12 | 2006-02-16 | イントロン，インコーポレーテッド | スプライセオソームにより媒介されるｒｎａトランス−スプライシングにおいて使用するための方法および組成物 |
| AU2003213270A1 (en) | 2002-02-25 | 2003-09-09 | Intronn, Inc. | Trans-splicing mediated imaging of gene expression |
| US7399753B2 (en) | 2002-02-25 | 2008-07-15 | Virxsys Corporation | Trans-splicing mediated photodynamic therapy |
| AU2003247505A1 (en) | 2002-06-05 | 2003-12-22 | University Of Iowa Research Foundation | Spliceosome mediated rna trans-splicing in stem cells |
| CA2488246A1 (en) | 2002-06-05 | 2003-12-18 | Intronn, Inc. | Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects using spliceosome mediated rna trans spling |
| US20040018622A1 (en) | 2002-07-17 | 2004-01-29 | Mitchell Lloyd G. | Spliceosome mediated RNA trans-splicing for correction of skin disorders |
| EP1579004B1 (en) | 2002-10-23 | 2010-06-16 | VIRxSYS Corporation | Screening methods for identification of efficient pre-trans-splicing molecules |
| WO2005070948A1 (en) | 2004-01-23 | 2005-08-04 | Intronn, Inc. | Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated rna trans splicing |
| JP2007518423A (ja) | 2004-01-23 | 2007-07-12 | イントロン、インコーポレイテッド | スプライセオソーム仲介型ｒｎａトランススプライシングを使用するアポａ−１及びその変異体の発現 |
| WO2006026611A2 (en) | 2004-08-31 | 2006-03-09 | Mitchell Lloyd G | Reverse transcriptase mediated rna gene expression |
| US7943374B2 (en) | 2005-08-21 | 2011-05-17 | Markus Hildinger | Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb |
| US20090214478A1 (en) | 2008-02-21 | 2009-08-27 | Alberto Auricchio | Method of treating ocular diseases by gene therapy |
| US8236557B2 (en) | 2008-05-28 | 2012-08-07 | University Of Missouri-Columbia | Hybrid-AAV vectors to deliver large gene expression cassette |
| EP2151248A1 (en) | 2008-07-30 | 2010-02-10 | Johann Bauer | Improved pre-mRNA trans-splicing molecule (RTM) molecules and their uses |
| AU2013234376B2 (en) * | 2008-10-22 | 2016-07-28 | Acucela, Inc. | Compounds for treating ophthalmic diseases and disorders |
| US8648053B2 (en) | 2010-10-20 | 2014-02-11 | Rosalind Franklin University Of Medicine And Science | Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for Usher syndrome |
| US9249425B2 (en) | 2011-05-16 | 2016-02-02 | The Trustees Of The University Of Pennslyvania | Proviral plasmids and production of recombinant adeno-associated virus |
| BR112014004895B1 (pt) * | 2011-09-05 | 2022-07-05 | Stichting Radboud Universitair Medisch Centrum | Oligonucleotídeos antissentido para o tratamento de amaurose congênita de leber |
| EP2872183B1 (en) | 2012-07-11 | 2018-09-26 | The Trustees Of The University Of Pennsylvania | Aav-mediated gene therapy for rpgr x-linked retinal degeneration |
| CN104955951A (zh) | 2012-10-16 | 2015-09-30 | 麻省理工学院 | 稳定的非多腺苷酸化rna的产生 |
| GB201219762D0 (en) | 2012-11-02 | 2012-12-19 | Bauer Johann | A RNA trans-splicing molecule (RTM) for use in the treatment of cancer |
| US10266845B2 (en) | 2013-02-08 | 2019-04-23 | The Trustees Of The University Of Pennsylvania | Enhanced AAV-mediated gene transfer for retinal therapies |
| US9567376B2 (en) | 2013-02-08 | 2017-02-14 | The Trustees Of The University Of Pennsylvania | Enhanced AAV-mediated gene transfer for retinal therapies |
| CA2909733C (en) | 2013-04-18 | 2023-10-17 | Fondazione Telethon | Effective delivery of large genes by dual aav vectors |
| WO2015009575A1 (en) | 2013-07-16 | 2015-01-22 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of disorders related to cep290 |
| WO2015138510A1 (en) | 2014-03-10 | 2015-09-17 | Editas Medicine., Inc. | Crispr/cas-related methods and compositions for treating leber's congenital amaurosis 10 (lca10) |
| WO2016005524A1 (en) | 2014-07-09 | 2016-01-14 | Lexogen Gmbh | Methods and products for quantifying rna transcript variants |
| RS63416B1 (sr) * | 2015-03-03 | 2022-08-31 | Fond Telethon | Sistem višestrukih vektora i njegove primene |
| EP3377116A4 (en) | 2015-11-19 | 2019-07-10 | The Trustees of The University of Pennsylvania | COMPOSITIONS AND METHODS FOR CORRECTING ECG-RELATED EYE DISEASE |
| EP3390634A4 (en) * | 2015-12-14 | 2019-08-14 | Cold Spring Harbor Laboratory | COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES |
| KR20200036912A (ko) * | 2017-07-31 | 2020-04-07 | 리플렉션 바이오테크놀러지스 리미티드 | 안과 질환을 위한 세포 모델 및 치료요법 |
| US11795455B2 (en) | 2017-07-31 | 2023-10-24 | Massachusetts Institute Of Technology | RNA cleavage-induced transcript stabilizer and uses thereof |
| CA3097004A1 (en) | 2018-04-17 | 2019-10-24 | The Trustees Of The University Of Pennsylvania | Trans-splicing molecules |
| WO2020214990A1 (en) | 2019-04-17 | 2020-10-22 | Ascidian Therapeutics, Inc. | Abca4 cell line and methods of use |
| WO2020214973A1 (en) | 2019-04-17 | 2020-10-22 | The Trustees Of The University Of Pennsylvania | Triple helix terminator for efficient rna trans-splicing |
| CA3138520C (en) | 2019-05-01 | 2023-10-10 | The Procter & Gamble Company | Probiotic bacterial strains that produce short chain fatty acids and compositions comprising same |
| AU2023269865A1 (en) | 2022-05-13 | 2024-11-21 | Ascidian Therapeutics, Inc. | Abca4 trans-splicing molecules |
-
2019
- 2019-04-17 CA CA3097004A patent/CA3097004A1/en active Pending
- 2019-04-17 KR KR1020207032936A patent/KR102866133B1/ko active Active
- 2019-04-17 KR KR1020257032132A patent/KR20250150157A/ko active Pending
- 2019-04-17 AU AU2019255708A patent/AU2019255708B2/en active Active
- 2019-04-17 MX MX2020010959A patent/MX2020010959A/es unknown
- 2019-04-17 US US17/047,496 patent/US11993776B2/en active Active
- 2019-04-17 BR BR112020021228-8A patent/BR112020021228A2/pt unknown
- 2019-04-17 EP EP19789043.7A patent/EP3781213A4/en active Pending
- 2019-04-17 CN CN201980040706.1A patent/CN112449605A/zh active Pending
- 2019-04-17 WO PCT/US2019/027981 patent/WO2019204514A1/en not_active Ceased
- 2019-04-17 JP JP2020557945A patent/JP7561624B2/ja active Active
-
2020
- 2020-10-13 IL IL278019A patent/IL278019A/en unknown
- 2020-10-15 MX MX2025007209A patent/MX2025007209A/es unknown
-
2024
- 2024-04-30 JP JP2024073380A patent/JP2024099770A/ja active Pending
- 2024-05-24 US US18/673,713 patent/US12442003B2/en active Active
-
2025
- 2025-09-17 US US19/331,448 patent/US20260078380A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021520837A5 (https=) | ||
| JP2024099770A5 (https=) | ||
| JP7707261B2 (ja) | 筋疾患の治療のための改変ａａｖカプシドポリペプチド | |
| CN112004925B (zh) | 具有降低的肝向性的AAV9和AAVrh74的杂合重组腺相关病毒血清型 | |
| ES2984259T3 (es) | Capside de aav modificada con peptidos | |
| JP6994018B2 (ja) | 新規アデノ随伴ウイルスキャプシドタンパク質 | |
| AU2016206518B2 (en) | Novel micro-dystrophins and related methods of use | |
| US20250161485A1 (en) | Aav capsid variants and uses thereof | |
| JP6363958B2 (ja) | Ａａｖ変異体 | |
| CN116209768A (zh) | 用于通过高变区交换工程化新杂合aav衣壳的方法 | |
| CN115996759A (zh) | 合成aav衣壳用于肌肉和中枢神经系统障碍的基因治疗的用途 | |
| JP2008509695A5 (ja) | 欠失可能なドメインタンパク質をコードする遺伝子におけるエクソンスキッピングのためのアデノ随伴ウイルスベクター | |
| JP2021534814A5 (https=) | ||
| WO2020142714A1 (en) | Aav expression cassette and aav vectors comprising the same | |
| JPWO2019204514A5 (https=) | ||
| US20220177529A1 (en) | Fusion protein for enhancing gene editing and use thereof | |
| JP2021534766A5 (https=) | ||
| JPWO2020082047A5 (https=) | ||
| WO2016037931A1 (en) | Nucleic acid constructs and expression vectors for gene therapy of acute porphyrias and other diseases | |
| WO2024126762A2 (en) | Recombinant adeno-associated virus gene therapy vectors with reduced liver tropism and enhanced transduction of cardiac cells for the therapy of heart diseases and diseases associated with heart dysfunction | |
| JP7811409B2 (ja) | 筋ジストロフィー治療のための遺伝子導入発現カセット | |
| EP4705318A2 (en) | Kidney-targeting aav capsids and methods of use thereof | |
| US20260115322A1 (en) | Recombinant tert-encoding viral genomes and vectors | |
| EP4337780B1 (en) | Recombinant tert-encoding viral genomes and vectors | |
| WO2025157259A1 (en) | Novel muscle-specific promoters |